Crossref
P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE
Value in Health · 2026-06 · 29 (6) · S17
DOI: 10.1016/j.jval.2026.03.082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Mina Yakoub und 5 weiteren Autor:innen.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yakoub, M., Moga, D., Delcher, C., Duncan, M., Adams, V., & Duprey, M. (2026). P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE. Value in Health, 29(6), S17. https://doi.org/10.1016/j.jval.2026.03.082
Vancouver
Yakoub M, Moga D, Delcher C, Duncan M, Adams V, Duprey M. P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE. Value in Health. 2026;29(6):S17. doi:10.1016/j.jval.2026.03.082
BibTeX
@article{Yakoub2026,
author = {Yakoub, Mina and Moga, Daniela and Delcher, Chris and Duncan, Meredith and Adams, Val and Duprey, Matthew},
title = {P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S17},
doi = {10.1016/j.jval.2026.03.082}
}
EUVIMED